Kaya Holdings (KAYS) Cash from Investing Activities (QoQ) (2014 - 2024)
Kaya Holdings (KAYS) Cash from Investing Activities (QoQ) (2014 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -73.40% |
| Sep 30, 2024 | 162.67% |
| Jun 30, 2024 | -291.97% |
| Jun 30, 2023 | -82.87% |
| Mar 31, 2019 | 39.32% |
| Dec 31, 2018 | 32.72% |
| Sep 30, 2018 | 38.13% |
| Jun 30, 2018 | -111.66% |
| Mar 31, 2018 | 47.44% |
| Dec 31, 2017 | 87.03% |
| Sep 30, 2017 | -508.55% |
| Jun 30, 2017 | -72.31% |
| Mar 31, 2017 | -93.04% |
| Dec 31, 2015 | -202.99% |
| Sep 30, 2015 | -776.98% |
| Jun 30, 2015 | 33.33% |
| Sep 30, 2014 | 95.78% |
| Jun 30, 2014 | -868.47% |
| Mar 31, 2014 | -583,600.00% |